Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20308542.
- Also identified by DOI 10.1073/pnas.0913360107 and PMC identifier 2852023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Annexin A1 (AnxA1) is a candidate regulator of the epithelial- to mesenchymal (EMT)-like phenotypic switch, a pivotal event in breast cancer progression. We show here that AnxA1 expression is associated with a highly invasive basal-like breast cancer subtype both in a panel of human breast cancer cell lines as in breast cancer patients and that AnxA1 is functionally related to breast cancer progression. AnxA1 knockdown in invasive basal-like breast cancer cells reduced the number of spontaneous lung metastasis, whereas additional expression of AnxA1 enhanced metastatic spread. AnxA1 promotes metastasis formation by enhancing TGFbeta/Smad signaling and actin reorganization, which facilitates an EMT-like switch, thereby allowing efficient cell migration and invasion of metastatic breast cancer cells.
Medical subject headings
- Annexin A1
- Breast Neoplasms
- Signal Transduction
- Transforming Growth Factor beta